Dr Hamza Zafar

All publications

Journal articles

• Zafar H, Neelam-Naganathan D, Middleton JT, Binmahfooz SK, Battersby C, Rogers D, Swift AJ & Rothman AMK (2023) Anatomical characterization of pulmonary artery and implications to pulmonary artery pressure monitor implantation. Scientific Reports, 13(1). View this article in WRRO
• Rothman AMK, Zafar H, Sandy R, Wright C, Mitra S, Ebah L, Ilyas D, Hanumapura P, Sebastien S, Khalifa A , Passman J et al (2023) A Subcutaneous Multiparameter Sensor With Integrated Interstitial Fluid Pressure Measurement for Remote Heart Failure Monitoring. JACC: Basic to Translational Science, 8(4), 386-388.
• Elhawaz A, Archer G, Zafar H, Fidock B, Barker N, Jones R, Rothman A, Hose R, Al-Mohammad A, Briffa N , Hunter S et al (2021) Left ventricular blood flow kinetic energy is associated with the six-minute walk test and left ventricular remodelling post valvular intervention in aortic stenosis. Quantitative imaging in medicine and surgery, 11(4), 1470-1482. View this article in WRRO
• Zafar H, Debowska A & Boduszek D (2021) Emotion regulation difficulties and psychopathology among Pakistani adolescents. Clinical Child Psychology and Psychiatry, 26(1), 121-139. View this article in WRRO
• Rothman AMK, Arnold ND, Abou-Hanna J, Forouzan O, Swift AJ, Dahaghin P, Konganige S, Middleton JT, Zafar H, Suvarna SK , Kiely DG et al (2020) Feasibility and safety of a telemetric pulmonary artery pressure monitoring system in acute and chronic porcine models of pulmonary hypertension.
• Alabed S, Garg P, Johns CS, Alandejani F, Shahin Y, Dwivedi K, Zafar H, Wild JM, Kiely DG & Swift AJ (2020) Cardiac magnetic resonance in pulmonary hypertension - an update. Current Cardiovascular Imaging Reports, 13(12). View this article in WRRO
• Omura J, Habbout K, Shimauchi T, Wu W-H, Breuils-Bonnet S, Tremblay E, Martineau S, Nadeau V, Gagnon K, Mazoyer F , Perron J et al (2020) Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension. Circulation, 142(15), 1464-1484.
• Barker N, Zafar H, Fidock B, Elhawaz A, Al-Mohammad A, Rothman A, Kiely DG, van der Geest RJ, Westenberg J, Swift AJ , Wild JM et al (2020) Age-associated changes in 4D flow CMR derived tricuspid valvular flow and right ventricular blood flow kinetic energy. Scientific Reports, 10(1). View this article in WRRO
• (2020) An exercise-based cardiac rehabilitation programme for AF patients in the NHS: a feasibility study. British Journal of Cardiology.

Conference proceedings papers

• Zafar H, Passman J, Sandy R, Wright C, Wright F, Evans H, Ebah L, Ilyas D, Hanumapura P, Sebastien S , Khalifa A et al (2023) BS74 Assessment of fluid status in porcine models of heart failure and pulmonary hypertension. Basic Science
• Patel J, Kiely DG, Roddis C, Charalampopoulos A, Thompson R, Pearson C, Dick J, Binmahfooz S, Lewis R, Taylor J , Ashraf C et al (2023) 196 The relationship of physical activity, heart rate variability, and night heart rate to established measures of clinical risk in patients with pulmonary arterial hypertension (pah). Stable IHD/Prevention/Hypertension/Lipids
• Battersby C, Condliffe R, Kiely DG, Elliot C, Middleton JT, Patel J, Neelam-Naganathan D, Lewis R, Binmahfooz S, Swift AJ , Hameed A et al (2023) 155 Effect of covid-19 infection and preventive public health measures on haemodynamics, activity and quality of life in patients with pulmonary arterial hypertension. Heart Failure
• Ashraf C, Taylor J, Roddis C, Toshner M, Middleton JT, Hurdman J, Thompson R, Kiely DG, Swift AJ, Charalampopoulos A , Roman S et al (2023) 154 Stability of daily physical activity as a remote measure of clinical risk in pulmonary arterial hypertension (pah). Heart Failure
• Varian F, Binmahfooz S, Condliffe R, Middleton JT, Rothman AMK, Patel J, Kiely DG, Hamilton N, Lewis R, Elliot C , Battersby C et al (2023) 158 Remote personalisation of pulmonary arterial hypertension therapy and application of a remote physiological risk score. Heart Failure
• Taylor J, Kiely DG, Hamilton N, Hurdman J, Dwivedi K, Pearson C, Charalampopoulos A, Zafar H, Reddy A, Lewis R , Patel J et al (2023) 153 Differences in physical activity, heart rate and heart variability during clinical worsening events in patients with pulmonary arterial hypertension (pah). Heart Failure
• Middleton J, Neelam-Naganathan D, Elliot C, Taylor J, Toshner M, Zafar H, Lewis R, Ashraf C, Binmahfooz S, Condliffe R , Durrington C et al (2023) 138 Physiological detection of clinical worsening and therapeutic response using implanted remote technologies in pah. Heart Failure
• Middleton J, Elliot C, Pearson C, Battersby C, Roman S, Armstrong I, Condliffe R, Watson L, Rothman AMK, Neelam-Naganathan D , Kiely DG et al (2023) 137 Design and validation of a physiological risk score for pulmonary arterial hypertension (pah). Heart Failure
• Durrington C, Battersby C, Holt L, Fairman A, salisbury T, Turton H, Watson L, Hameed A, Charalampopoulos A, Elliot C , Rothman A et al (2023) Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAH (REPEAT-PAH). B57. INTERMEDIATES, CORRELATES, AND SURROGATES, OH MY!: NOVEL END POINTS AND ASSESSMENTS IN PVD
• Middleton JT, Binmafooz S, Zafar H, Patel J, Giri D, Battersby C, Toshner M, Reddy A, Lewis R, Durrington C , Swift A et al (2022) S92 Remote monitoring enabled evaluation of risk and physiological response to therapeutic escalation and clinical worsening in patients with pulmonary hypertension. ‘The Sixth Sense’ – Prognostication in pulmonary vascular disease
• Patel J, Middleton J, Battersby C, Zafar H, Binmahfooz S, Neelam-Naganathan D, Toshner M, Reddy A, Lewis R, Watson L , Swift A et al (2022) S91 Remote monitored physical activity is related to established measures of clinical risk in patients with pulmonary arterial hypertension. ‘The Sixth Sense’ – Prognostication in pulmonary vascular disease
• Battersby CP, Middleton JT, Zafar H, Binmahfooz SK, Patel J, Neelam-Naganathan D, Toshner M, Reddy A, Lewis R, Watson L , Swift A et al (2022) P81 Effect of COVID-19 infection and preventive public health measures on haemodynamics, activity and quality of life in patients with pulmonary arterial hypertension. ‘Contagion’ – The impact of COVID-19
• Durrington C, Battersby C, Holt L, Fairman A, Salisbury T, Turton H, Watson L, Hameed AG, Charalampopoulos A, Elliot CA , Rothman AMK et al (2022) P38 Assessing the repeatability of NT-proBNP testing using laboratory and point of care testing in PAH (REPEAT-PAH). ‘Mission (Im)possible I’ – Pulmonary vascular disease
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Giri D, Battersby C, Toshner M, Reddy A, Lewis R, Condliffe R , Elliot C et al (2022) Abstract 13553: Remote Monitoring of the Haemodynamic Response to Clinically Indicated Therapeutic Escalation and Clinical Worsening Events in Patients With Pulmonary Arterial Hypertension. Circulation, Vol. 146(Suppl_1)
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Neelam Naganathan DG, Battersby C, Toshner M, Reddy A, Lewis R, Swift AJ , Condliffe R et al (2022) Abstract 13527: The Development of a Remote Pulmonary Arterial Hypertension Risk Score Utilising Remote Monitoring Technology to Monitor Parameters Associated With Mortality in Pulmonary Arterial Hypertension. Circulation, Vol. 146(Suppl_1)
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Naganathan DGN, Battersby C, Toshner M, Reddy A, Lewis R, Swift AJ , Condliffe R et al (2022) The Development of a Remote Pulmonary Arterial Hypertension Risk Score Utilising Remote Monitoring Technology to Monitor Parameters Associated With Mortality in Pulmonary Arterial Hypertension. CIRCULATION, Vol. 146
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Giri D, Battersby C, Toshner M, Reddy A, Lewis R, Condliffe R , Elliot C et al (2022) Remote Monitoring of the Haemodynamic Response to Clinically Indicated Therapeutic Escalation and Clinical Worsening Events in Patients With Pulmonary Arterial Hypertension. CIRCULATION, Vol. 146
• Middleton J, Zafar H, Kiely DG & Rothman A (2021) 124 Comparing the safety and feasibility of implanting pulmonary artery pressure monitors via the internal jugular vein compared to standard femoral venous access in patients with pulmonary arterial hypertension. Heart failure
• Middleton J, Zafar H, Reddy A, Martin C, Thompson R, Swift A, Toshner M, Kiely DG & Rothman A (2021) 121 Effect of UK COVID-19 public health measures on activity and quality of life in patients with pulmonary arterial hypertension. Heart failure
• Middleton JT, Konganige S, Dahaghin P, Zafar H, Reddy A, Martin C, Thompson AAR, Swift AJ, Morris P, Condliffe R , Morrell NW et al (2020) Abstract 15636: Effect of COVID-19 Public Health Measures on Activity and Quality of Life in Patients With Pulmonary Arterial Hypertension. Circulation, Vol. 142(Suppl_3) (pp A15636). Virtual conference, 15 November 2020 - 15 November 2020. View this article in WRRO
• Omura J, Habbout K, Shimauchi T, Breuils-Bonnet S, Tremblay E, Martineau S, Nadeau V, Potus F, Archer SL, Lin J , Zafar H et al (2020) Long Non-Coding RNA H19 Promotes Right Ventricular Failure in PAH. A93. TRANSLATIONAL RESEARCH; EARLY CLINICAL FINDINGS AND OMICS ADVENTURE IN PULMONARY HYPERTENSION: FROM BIOMARKERS TO NEW THERAPEUTIC TARGETS
• Omura J, Habbout K, Shimauchi T, Breuils-Bonnet S, Tremblay E, Martineau S, Nadeau V, Potus F, Archer SL, Lin J , Zafar H et al (2020) Identification of Circulating Long Non-Coding RNA H19 as a Novel Biomarker for Right Ventricular Failure Associated with Pulmonary Arterial Hypertension. C105. WITH ALL MY HEART: SEX, ESTROGEN, AND RIGHT VENTRICLE IN PULMONARY VASCULAR DISEASE AND BEYOND
• Mills M, Johnson E, Zafar H, Horwood A, Lax N, Charlesworth S, Gregory A, Lee J, Sahu J, Kirkwood G , Kelland N et al (2019) 31 Utilisation of an existing exercise-based cardiac rehabilitation programme for patients with atrial fibrillation in the national health service: putting current services to good use. Cardiac Rhythm Management

Preprints

• Varian F, Dick J, Battersby C, Roman S, Ablott J, Watson L, Binmahfooz S, Zafar H, Colgan G, Cannon J , Suntharalingam J et al (2023) Pulmonary Hypertension: Intensification and Personalisation of Combination Rx (PHoenix): A phase IV randomised trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies, Cold Spring Harbor Laboratory.
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Ashraf C, Jake , Neelam-Naganathan D, Battersby C, Pearson C, Roddis C , Roman S et al (2023) Remote monitored physiological response to therapeutic escalation and clinical worsening in patients with pulmonary arterial hypertension, Cold Spring Harbor Laboratory.
• Zafar H, Neelam-Naganathan D, Middleton JT, Rogers D, Swift AJ, Rothman A, Binmahfooz SK & Battersby C (2022) Pulmonary Artery Anatomical Characterization: Relevance to Pulmonary Artery Pressure Sensors, Research Square Platform LLC.